Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (1): 76-81.DOI: 10.3969/j.issn.1673-8640.2018.01.015
• Orginal Article • Previous Articles Next Articles
WU Dawei, NING Li, WEI Dianjun
Received:
2017-01-09
Published:
2021-03-18
CLC Number:
WU Dawei, NING Li, WEI Dianjun. Determinations of cardiac surgery-associated acute kidney injury[J]. Laboratory Medicine, 2018, 33(1): 76-81.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.01.015
[1] | REDDY S L,GRAYSON A D,GRIFFITHS E M,et al.Logistic risk model for prolonged ventilation after adult cardiac surgery[J]. Ann Thorac Surg,2007,84(2):528-536. |
[2] | MENTZER R M JR,OZ M C,SLADEN R N,et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial[J]. J Am Coll Cardiol,2007,49(6):716-726. |
[3] | MEERSCH M,ZARBOCK A.Prevention of cardiac surgery-associated acute kidney injury[J]. Curr Opin Anaesthesiol,2017,30(1):76-83. |
[4] | WYCKOFF T,AUGOUSTIDES J G.Advances in acute kidney injury associated with cardiac surgery:the unfolding revolution in early detection[J]. J Cardiothorac Vasc Anesth,2012,26(2):340-345. |
[5] | BELLOMO R,RONCO C,KELLUM J A,et al.Acute renal failure-definition,outcome measures,animal models,fluid therapy and information technology needs:the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care,2004,8(4):R204-R212. |
[6] | CHANG C H,LIN C Y,TIAN Y C,et al.Acute kidney injury classification:comparison of AKIN and RIFLE criteria[J]. Shock,2010,33(3):247-252. |
[7] | KUNZENDORF U,HAASE M,RÖLVER L,et al..Novel aspects of pharmacological therapies for acute renal failure[J]. Drugs,2010,70(9):1099-1114. |
[8] | MAO H,KATZ N,ARIYANON W,et al.Cardiac surgery-associated acute kidney injury[J]. Cardiorenal Med,2013,3(3):178-199. |
[9] | THAKAR C V,ARRIGAIN S,WORLEY S,et al.A clinical score to predict acute renal failure after cardiac surgery[J].J Am Soc Nephrol,2005,16(1):162-168. |
[10] | CAMIN R M,COLS M,CHEVARRIA J L,et al.Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors,diuretics and NSAIDS:"The Triple Whammy"[J]. Nefrologia,2015,35(2):197-206. |
[11] | SEELIGER E,SENDESKI M,RIHAL C S,et al.Contrast-induced kidney injury:mechanisms,risk factors,and prevention[J]. Eur Heart J,2012,33(16):2007-2015. |
[12] | MEHTA R H,CASTELVECCHIO S,BALLOTTA A,et al.Association of gender and lowest hematocrit on cardiopulmonary bypass with acute kidney injury and operative mortality in patients undergoing cardiac surgery[J]. Ann Thorac Surg,2013,96(1):133-140. |
[13] | SUEN W S,MOK C K,CHIU S W,et al.Risk factors for development of acute renal failure(ARF) requiring dialysis in patients undergoing cardiac surgery[J].Angiology,1998,49(10):789-800. |
[14] | MANGANO C M,DIAMONDSTONE L S,RAMSAY J G,et al.Renal dysfunction after myocardial revascularization:risk factors,adverse outcomes,and hospital resource utilization.The Multicenter Study of Perioperative Ischemia Research Group[J].Ann Intern Med,1998,128(3):194-203. |
[15] | MACEDO E,BOUCHARD J,SOROKO S H,et al.Fluid accumulation,recognition and staging of acute kidney injury in critically-ill patients[J]. Crit Care,2010,14(3):R82. |
[16] | RISTIKANKARE A,PÖYHIÄR,KUITUNEN A,et al..Serum cystatin C in elderly cardiac surgery patients[J]. Ann Thorac Surg,2010,89(3):689-694. |
[17] | VAIDYA V S,FERGUSON M A,BONVENTRE J V.Biomarkers of acute kidney injury[J]. Annu Rev Pharmacol Toxicol,2008,48:463-493. |
[18] | COCA S G,PARIKH C R.Urinary biomarkers for acute kidney injury:perspectives on translation[J]. Clin J Am Soc Nephrol,2008,3(2):481-490. |
[19] | 徐兴凯,李岩,余猛进,等. 尿中性粒细胞明胶酶相关脂质运载蛋白在危重病患者急性肾损伤早期诊断中的意义[J]. 中华急诊医学杂志,2013,22(5):505-510. |
[20] | MISHRA J,DENT C,TARABISHI R,et al.Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet,2005,365(9466):1231-1238. |
[21] | PERRY T E,MUEHLSCHLEGEL J D,LIU K Y,et al.Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients[J]. Anesth Analg,2010,110(6):1541-1547. |
[22] | MCLLROY D R,WAGENER G,LEE H T.Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery:the effect of baseline renal function on diagnostic performance[J].Clin J Am Soc Nephrol,2010,5(2):211-219. |
[23] | 杨清,周玉杰,刘晓丽,等. 胱蛋白酶抑制素 C 对冠心病合并肾功能不全患者对比剂急性肾损伤的诊断价值[J]. 中国医药,2013,8(5):589-591. |
[24] | 李称才,李荣,何涛,等. 尿肾损伤分子-1在早期诊断急性梗阻性化脓性胆管炎并发急性肾损伤中的应用价值[J]. 中华肝脏外科手术学电子杂志,2013,2(5):318-321. |
[25] | PARIKH C R,MISHRA J,THIESSEN-PHILBROOK H,et al.Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery[J]. Kidney Int,2006,70(1):199-203. |
[26] | PARICK C R,COCA SG,THIESSEN-PHILBROOK H,et al.Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery[J]. J Am Soc Nephrol,2011,22(9):1748-1757. |
[27] | LIU K D,VIJAYAN A,ROSNER M H.Clinical adjudication in acute kidney injury studies:findings from the pivotal TIMP-2*IGFBP7 biomarker study[J]. Nephrol Dial Transplant,2016,31(10):1641-1646. |
[28] | MORIGUCHI J,INOUE Y,KAMIYAMA S,et al.N-acetyl-beta-D-glucosaminidase(NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas[J]. Toxicol Lett,2009,190(1):1-8. |
[29] | 田漫漫,赵双平. 尿Sema3A对重症监护病房患者急性肾损伤的早期诊断价值[J]. 中华医学杂志,2015,95(19):1457-1462. |
[30] | VIAZZI F,RAMESH G,JAYAKUMAR C,et al.Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease:a nested case-control study[J]. J Nephrol,2015,28(3):315-320. |
[31] | RANGANATHAN P,JAYAKUMAR C,MOHAMED R,et al.Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury[J]. Am J Physiol Renal Physiol,2014,307(2):F183-F194. |
[32] | MOHAMED R,RANGANATHAN P,JAYAKUMAR C,et al.Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice[J]. J Mol Med(Berl),2014,92(12):1245-1256. |
[33] | 王依屹,张珏,鲁传翠,等. 血清NGAL、Cys C和尿NAG联合检测在糖尿病肾病诊断中的临床意义[J]. 检验医学,2015,30(11):1096-1099. |
[1] | SUN Zepeng, WANG Hongbin, WANG Jiandong, SONG Dewei, XIAO Peng. Analysis and progress of peptide and protein biomarker methodology for myocardial injury [J]. Laboratory Medicine, 2023, 38(8): 784-789. |
[2] | ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598. |
[3] | GAO Feng. Clinical application of novel tumor biomarkers:prospects and challenges [J]. Laboratory Medicine, 2023, 38(4): 303-306. |
[4] | ZHOU Furong, LI Yanzhu, LIU Yonggan. Application of lncRNA SNP in colorectal cancer susceptibility prediction and prognosis assessment [J]. Laboratory Medicine, 2023, 38(12): 1206-1210. |
[5] | LU Qiyuan, LU Jianhua. Biomarker research progress for the diagnosis of periprosthetic joint infection [J]. Laboratory Medicine, 2023, 38(10): 997-1002. |
[6] | CHEN Xuewei, LI Yirong. Candidate biomarkers in metabolic syndrome based on GEO database [J]. Laboratory Medicine, 2023, 38(1): 32-38. |
[7] | WU Yating, LI Zhuolin, LEI Yan, JIA Ruxue, ZHANG Shenghang, WANG Shuiliang. Research progress of miRNA in urine as a biomarker for common malignant tumors [J]. Laboratory Medicine, 2023, 38(1): 94-99. |
[8] | WANG Rui, LI Zhaoyan, ZHAO Aiguang. Application of circulating tumor DNA detection in the diagnosis and treatment of gastric cancer [J]. Laboratory Medicine, 2022, 37(9): 877-881. |
[9] | WU Yanqian, YU Chong, SHEN Lu, ZHENG Haoran, HONG Yeting. Research progress of body fluid piRNA as a potential biomarker of disease [J]. Laboratory Medicine, 2022, 37(8): 782-786. |
[10] | FENG Xueqing, JU Yi, LI Qing, JIN Zhonggan. Research progress of electrochemical aptasensors for the determination of biomarkers [J]. Laboratory Medicine, 2022, 37(5): 477-482. |
[11] | HUANG Xiaofeng, FAN Xueming, YAO Tianyue, YUAN Wenhua, ZHAO Zhiyun, SONG Yunxiao. Correlation between red cell distribution width and prostate cancer [J]. Laboratory Medicine, 2021, 36(6): 590-595. |
[12] | GAO Dongtian, LIU Lihua, SHEN Aihua, SUN Yin. Progress of IPAI experimental diagnosis [J]. Laboratory Medicine, 2021, 36(4): 453-461. |
[13] | WANG Qianqing, HONG Juan, DU Chao, CHU Qinghua. Clinical role of serum cathepsin D determination in non-alcoholic fatty liver disease [J]. Laboratory Medicine, 2020, 35(6): 578-582. |
[14] | MA Yingbo, CAO Wenjun. Research progress on neutrophil to lymphocyte ratio in eye diseases [J]. Laboratory Medicine, 2020, 35(5): 501-505. |
[15] | LIU Yan, LONG Yin, PAN Weijie, ZHANG Tong, WENG Wenhao, YU Ying. Role of fecal DNA level of Fusobacterium nucleatum and clbA+ Escherichia coli in the diagnosis of colorectal cancer [J]. Laboratory Medicine, 2020, 35(4): 314-317. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||